Sintx Technologies, Inc.

SINT ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $95.0K $11.2M $15.2M $19.5M $22.8M $22.3M
Cost of Revenue $56.0K $6.4M $3.8M $6.3M $7.9M $7.0M
Gross Profit $39.0K $4.9M $11.4M $13.2M $14.9M $15.3M
Gross Margin 41.1% 43.4% 75.2% 67.9% 65.3% 68.4%
Operating Expenses
Research & Development $3.0M $3.5M $6.3M $6.4M $6.7M $3.5M
SG&A Expense $3.9M $3.7M $6.3M $6.4M $13.6M $5.8M
Operating Income $-13.1M $-7.5M $-11.5M $-12.0M $-24.2M $-10.3M
Operating Margin -13,806.3% -66.7% -75.8% -61.9% -106.2% -46.3%
Interest Expense $3.7M $1.9M
Pretax Income $-9.7M $-5.8M $-14.8M $-23.9M $-32.6M $-8.3M
Income Tax Expense
Net Income $-8.7M $-9.3M $-14.8M $-23.9M $-32.6M $-8.3M
Net Margin -9,107.4% -83.1% -97.0% -122.9% -143.1% -37.1%
EPS (Basic) $-0.03 $0.00 $-0.01 $-0.03 $-0.02 $-0.01
EPS (Diluted) $-0.03 $0.00 $-0.01 $-0.03 $-0.02 $-0.01
Shares Outstanding (Basic) 898.4M 7.34B 5.62B 2.24B 4.33B 1.47B
Shares Outstanding (Diluted) 945.8M 7.34B 5.62B 2.24B 4.33B 1.47B
Dividends Per Share
← Newer Page 2 of 2 Older →